SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus - Covid 19 Information Sharing Forum

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Vassar David10/17/2025 12:58:00 AM
  Read Replies (3) of 5928
 
There’s been ongoing discussion about Ivermectin For Humans and its potential connection to COVID-19 treatment and prevention. Ivermectin is a well-known antiparasitic medicine that’s been safely used in humans for decades to treat various parasitic infections.
During the pandemic, researchers began exploring whether Ivermectin could have antiviral or immune-modulating effects against the coronavirus. While some early lab results looked promising, most major health authorities — including the FDA, WHO, and EMA — have stated that more research is needed to confirm its effectiveness for COVID-19.

Many people are curious about the science behind Ivermectin for humans, especially because of its long record of safe use at prescribed doses. However, it’s important to remember that dosing and formulation for humans differ from veterinary use.

If anyone is considering Ivermectin or any alternative approaches related to COVID-19, it’s always best to rely on qualified medical advice and verified information sources. Continued research may help clarify how, when, or if Ivermectin could play a role in human viral infections in the future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext